223 related articles for article (PubMed ID: 31928169)
41. Prevention of relapse of Graves' disease by treatment with an intrathyroid injection of dexamethasone.
Mao XM; Li HQ; Li Q; Li DM; Xie XJ; Yin GP; Zhang P; Xu XH; Wu JD; Chen SW; Wang SK
J Clin Endocrinol Metab; 2009 Dec; 94(12):4984-91. PubMed ID: 19850691
[TBL] [Abstract][Full Text] [Related]
42. No association between Fas A/G polymorphism and therapeutic effects induced by methimazole treatment for Graves' disease in Northern Chinese.
Li P; Li Q; Chen L; Sun Y; Zhang J
Pharmazie; 2008 Oct; 63(10):748-50. PubMed ID: 18972838
[TBL] [Abstract][Full Text] [Related]
43. Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking.
Salvi M; Pedrazzoni M; Girasole G; Giuliani N; Minelli R; Wall JR; Roti E
Eur J Endocrinol; 2000 Aug; 143(2):197-202. PubMed ID: 10913938
[TBL] [Abstract][Full Text] [Related]
44. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan.
Huang CN; Hsu TC; Chou HH; Tsay GJ
J Formos Med Assoc; 2004 Apr; 103(4):274-9. PubMed ID: 15175822
[TBL] [Abstract][Full Text] [Related]
45. Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' disease.
Nagasaki T; Inaba M; Kumeda Y; Fujiwara-Ueda M; Hiura Y; Nishizawa Y
Biomed Pharmacother; 2007 Sep; 61(8):472-6. PubMed ID: 17420111
[TBL] [Abstract][Full Text] [Related]
46. Serial analysis of the effects of methimazole therapy on circulating B cell subsets in Graves' disease.
Corrales JJ; Orfao A; López A; Ciudad J; Mories MT
J Endocrinol; 1996 Nov; 151(2):231-40. PubMed ID: 8958783
[TBL] [Abstract][Full Text] [Related]
47. Influence of methimazole and radioactive iodine treatment in the serum levels of the chemokine CXCL10 in hyperthyroid patients with Graves' disease.
Leite AC; Pedro AB; Romaldini JH
Horm Metab Res; 2011 Mar; 43(3):194-9. PubMed ID: 21283953
[TBL] [Abstract][Full Text] [Related]
48. Treatment of Graves' disease with methimazole in children alters the proliferation of Treg cells and CD3+ T lymphocytes.
Klatka M; Kaszubowska L; Grywalska E; Wasiak M; Szewczyk L; Foerster J; Cyman M; Rolinski J
Folia Histochem Cytobiol; 2014; 52(1):69-77. PubMed ID: 24802963
[TBL] [Abstract][Full Text] [Related]
49. Treatment of Graves' hyperthyroidism with thionamides: a position paper on indications and safety in pregnancy.
Tonacchera M; Chiovato L; Bartalena L; Cavaliere AF; Vitti P
J Endocrinol Invest; 2020 Feb; 43(2):257-265. PubMed ID: 31784912
[TBL] [Abstract][Full Text] [Related]
50. RELATIONSHIP BETWEEN THE EFFECTIVENESS OF INORGANIC IODINE AND THE SEVERITY OF GRAVES THYROTOXICOSIS: A RETROSPECTIVE STUDY.
Honda A; Uchida T; Komiya K; Goto H; Takeno K; Sato J; Suzuki R; Himuro M; Watada H
Endocr Pract; 2017 Dec; 23(12):1408-1413. PubMed ID: 29144795
[TBL] [Abstract][Full Text] [Related]
51. Management of Neonates Born to Mothers With Graves' Disease.
van der Kaay DC; Wasserman JD; Palmert MR
Pediatrics; 2016 Apr; 137(4):. PubMed ID: 26980880
[TBL] [Abstract][Full Text] [Related]
52. A hyperthyroid patient with Graves' disease who was strongly resistant to methimazole: investigation on possible mechanisms of the resistance.
Li H; Okuda J; Akamizu T; Mori T
Endocr J; 1995 Oct; 42(5):697-704. PubMed ID: 8574295
[TBL] [Abstract][Full Text] [Related]
53. [Fluctuations in the titers of anti-thyroid hormone and anti-thyroglobulin antibodies in 4 cases of Graves' disease during long-term treatment period].
Komaki T; Sakata S; Nakamura S; Matsuda M; Kojima N; Takuno H; Miura K
Nihon Naibunpi Gakkai Zasshi; 1989 Jul; 65(7):627-39. PubMed ID: 2583311
[TBL] [Abstract][Full Text] [Related]
54. Clinical efficacy of Yingliu mixture combined with metimazole for treating diffuse goitre with hyperthyroidism and its impact on related cytokines.
Yang H; Cong Y; Wu T; Tang H; Ma M; Zeng J; Zhang W; Lian Z; Yang X
Pharm Biol; 2017 Dec; 55(1):258-263. PubMed ID: 27927064
[TBL] [Abstract][Full Text] [Related]
55. Short-term effects of combined treatment with potassium bromide and methimazole in patients with Graves' disease.
Li D; Pei H; Li X; Liu X; Li X; Xie Y
J Endocrinol Invest; 2012 Dec; 35(11):971-4. PubMed ID: 22186223
[TBL] [Abstract][Full Text] [Related]
56. [Graves' Disease].
Allelein S; Schott M
Dtsch Med Wochenschr; 2021 Oct; 146(20):1337-1343. PubMed ID: 34644794
[TBL] [Abstract][Full Text] [Related]
57. Clinical Studies on Potassium Iodide-induced Painless Thyroiditis in 11 Graves' Disease Patients.
Kamijo K
Intern Med; 2021 Jun; 60(11):1675-1680. PubMed ID: 33431733
[TBL] [Abstract][Full Text] [Related]
58. Anti-glutamic acid decarboxylase antibody in Graves' disease is a possible indicator for the unlikelihood of going into remission with antithyroid agents.
Yoshihara A; Isozaki O; Okubo Y; Takano K
Endocr J; 2009; 56(2):269-74. PubMed ID: 19139594
[TBL] [Abstract][Full Text] [Related]
59. Risk factors for neonatal thyroid dysfunction in pregnancies complicated by Graves' disease.
Uenaka M; Tanimura K; Tairaku S; Morioka I; Ebina Y; Yamada H
Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():89-93. PubMed ID: 24726178
[TBL] [Abstract][Full Text] [Related]
60. Incidence of Neonatal Hyperthyroidism Among Newborns of Graves' Disease Patients Treated with Radioiodine Therapy.
Yoshihara A; Iwaku K; Noh JY; Watanabe N; Kunii Y; Ohye H; Suzuki M; Matsumoto M; Suzuki N; Tadokoro R; Sekiyama C; Hiruma M; Sugino K; Ito K
Thyroid; 2019 Jan; 29(1):128-134. PubMed ID: 30426886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
